Team
At Recalivape, innovation is intentional, strategic, and interdisciplinary. Our leadership and advisors guide scientific, clinical, and regulatory direction, while our engineering team executes across software, electrical, and mechanical systems to translate insight into deployable technology. Together, we are building a platform that redefines how society addresses substance dependence.
Founder & CEO
Farid Manshaii is an interdisciplinary researcher and entrepreneur whose academic foundation spans neuroscience, bioengineering, psychology, and addiction pharmacology, cultivated through rigorous training at UCLA and Keck Graduate Institute. As the Founder and CEO of Recalivape, he applies his scientific expertise and systems thinking to pioneer adaptive health technologies, architect innovative solutions, and drive long-term societal impact that transcends conventional technological approaches.
Platform & Systems Development
Conrad Lindberg
Electrical Engineer
Conrad Lindberg is an electrical engineer with extensive experience in applied electronics, system design, and hardware development across medical and industrial applications. He has contributed to multiple patented technologies, including diagnostic systems, power electronics, and control systems, reflecting a strong focus on practical engineering solutions. At Recalivape, he supports the electrical architecture and sensor integration for AMSTAD and SleeveSense, ensuring reliable data acquisition and system performance.
Cameron Yartz
Mechanical Engineer
Cameron Yartz is a mechanical engineer with expertise in product design, CAD modeling, and design-for-manufacturing methodologies. He has experience translating early-stage concepts into manufacturable systems through iterative prototyping, hardware development, and engineering optimization. At Recalivape, he leads mechanical design efforts for AMSTAD and SleeveSense, overseeing device architecture, testing apparatus development, and ensuring structural integrity, usability, and scalability for production.
Amazigh Halzoun
Software Developer
Amazigh Halzoun is a fullstack developer specializing in scalable web and mobile application development, with experience in modern frameworks and cloud-integrated systems. He focuses on building robust, user-centric platforms that enable real-time data processing and seamless cross-platform functionality. At Recalivape, he develops the digital infrastructure supporting behavioral tracking, analytics, and user feedback systems.
Board of Advisors
Dr. Edythe London
Clinical and Neuroscience Advisor
Dr. Edythe London is an internationally recognized neuroscientist and pharmacologist, currently serving as a distinguished professor at UCLA. Specializing in addiction research, she pioneers the use of advanced brain imaging technologies such as PET and fMRI to study substance use disorders. With over 300 published research articles, Dr. London ensures the clinical and scientific rigor of Recalivape’s research initiatives and guides the translational impact of our innovations.
Shepard Bentley
Regulatory Strategy Advisor
Shepard Bentley, President and Principal Consultant at Bentley Biomedical Consulting, LLC, is an expert in regulatory affairs for medical devices and pharmaceuticals. With over 30 years of experience, including successful leadership at Rising Star and Volcano Therapeutics, he advises Recalivape on FDA and Health Canada regulatory pathways, compliance frameworks, and strategic market entry initiatives, ensuring our technologies meet global standards for approval and adoption.
Jay Goth
Innovation and Commercialization Advisor
Jay Goth is a serial entrepreneur and innovation strategist with more than 40 years of cross-sector experience spanning genomics, energy, technology, and finance. As CEO of Burble Creativity Inc. and Founder of Redtail Capital, he specializes in scaling startups and driving strategic growth initiatives. Recognized as the 2016 SBA Small Business Champion of the Year, Jay provides Recalivape with critical expertise in commercialization strategies, startup development, and strategic fundraising.
Together, our leadership team combines deep scientific knowledge, clinical acumen, regulatory insight, and entrepreneurial vision—positioning Recalivape to lead the next generation of personalized, data-driven addiction treatment technologies.